Subtype
Hepatopancreatobiliary Carcinoma
CI-CAN-00002859Explore in graph →
1,360 active trials21 approved drugs69 evidence items
- NCIt
- C214986
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002859Explore in graph →
Clinical trials
5,150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (645)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01721941 | TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma | unknown | Phase 1 | 20 | Scripps Clinic Cancer CenterOTHER | 1 | Jul 4, 2014 | clinicaltrials |
| NCT02178280 | Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma | unknown | Phase 1 / Phase 2 | 60 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jun 30, 2014 |
| clinicaltrials |
| NCT02018757 | Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC(SEATH) | unknown | Phase 2 | 250 | First Hospital of China Medical UniversityOTHER | 1 | May 28, 2014 | clinicaltrials |
| NCT02148562 | Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity | unknown | — | 274 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 28, 2014 | clinicaltrials |
| NCT02131441 | Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection | unknown | N/A | 2 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01957241 | PLA for HCC and Esophageal ca Serum | unknown | — | 164 | National Taiwan University HospitalOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT02103179 | VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)(VEGF ECC) | unknown | — | 20 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Apr 3, 2014 | clinicaltrials |
| NCT01272557 | Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial(SoraDox) | unknown | Phase 2 | 170 | PD Dr. med. Matthias DollingerOTHER | 1 | Apr 1, 2014 | clinicaltrials |
| NCT02074202 | To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma | unknown | Phase 3 | 150 | National Taiwan University HospitalOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT02070822 | 3T MRI to Predict TACE Response of HCC | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02051283 | Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC | unknown | — | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 31, 2014 | clinicaltrials |
| NCT02036216 | Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma. | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 2 | Jan 14, 2014 | clinicaltrials |
| NCT01997957 | A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC(SOON) | unknown | Phase 4 | 110 | Zhu XuOTHER | 1 | Nov 28, 2013 | clinicaltrials |
| NCT01930383 | Circulating Tumor Cells for Hepatocellular Carcinoma(CTCs for HCC) | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Nov 14, 2013 | clinicaltrials |
| NCT01957618 | The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy(CTEAM) | unknown | — | 1,500 | National Taiwan University HospitalOTHER | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01942629 | Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas | unknown | — | 300 | Rambam Health Care CampusOTHER | 0 | Sep 16, 2013 | clinicaltrials |
| NCT01924624 | Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma | unknown | N/A | 140 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Aug 16, 2013 | clinicaltrials |
| NCT01919151 | Micrometastasis in Gastrointestinal Cancer | unknown | — | 500 | Oslo University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01917370 | VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway(icc) | unknown | — | 20 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 6, 2013 | clinicaltrials |
| NCT01894269 | Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication | unknown | Phase 4 | 200 | Sun Yat-sen UniversityOTHER | 1 | Jul 23, 2013 | clinicaltrials |
| NCT01892072 | VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway(HCC) | unknown | — | 50 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT01448668 | Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV) | unknown | — | 220 | IFAG AGINDUSTRY | 2 | Jul 2, 2013 | clinicaltrials |
| NCT01861912 | Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma(ACTION) | unknown | Phase 2 / Phase 3 | 258 | Guangdong Provincial People's HospitalOTHER | 0 | Jun 5, 2013 | clinicaltrials |
| NCT01858207 | Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient | unknown | Phase 2 | 60 | Shi-Ming LinOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT01833286 | TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma(TACE-RFA) | unknown | Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Apr 16, 2013 | clinicaltrials |
| NCT01821482 | A Study of DC-CIK to Treat Hepatocellular Carcinoma | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01739465 | Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma | unknown | Phase 2 / Phase 3 | 120 | Guangzhou Medical UniversityOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01668381 | Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy | unknown | — | 20 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT01764438 | Utility Study of Primovist-MRI on HCC Staging(PrimovistMRI) | unknown | — | 174 | Inha University HospitalOTHER | 1 | Jan 9, 2013 | clinicaltrials |
| NCT01567930 | Temsirolimus as Second-line Therapy in HCC | unknown | Phase 2 | 25 | University of Tennessee Cancer InstituteOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT01392131 | Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 40 | Clinical Research Organization, Dhaka, BangladeshOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT01575717 | The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List | unknown | N/A | 50 | Andrea BranchOTHER | 1 | Oct 24, 2012 | clinicaltrials |
| NCT00843934 | Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma(ACE500) | unknown | Phase 2 / Phase 3 | 450 | Nihon UniversityOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01677468 | Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma | unknown | N/A | 250 | Hallym University Medical CenterOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT01442324 | Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma | unknown | N/A | 5 | Azienda Ospedaliera di PadovaOTHER | 1 | Jul 18, 2012 | clinicaltrials |
| NCT01549795 | Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy | unknown | N/A | 33 | Azienda Ospedaliera di PadovaOTHER | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00522405 | Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma | unknown | Phase 2 / Phase 3 | — | All India Institute of Medical SciencesOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01438437 | Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis | unknown | Phase 4 | 54 | All India Institute of Medical SciencesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01438450 | Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma(OTCHCC) | unknown | Phase 2 / Phase 3 | 74 | All India Institute of Medical SciencesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01607788 | Prospective Liver Tumor (ProLiT) Database(ProLit) | unknown | — | 500 | University of Geneva, SwitzerlandOTHER | 1 | May 30, 2012 | clinicaltrials |
| NCT01605734 | TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma | unknown | Phase 2 | 120 | Shandong Cancer Hospital and InstituteOTHER | 1 | May 25, 2012 | clinicaltrials |
| NCT01556815 | Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma | unknown | Phase 2 | 40 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 25, 2012 | clinicaltrials |
| NCT01570075 | Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria | unknown | Phase 4 | 180 | Sun Yat-sen UniversityOTHER | 1 | Apr 4, 2012 | clinicaltrials |
| NCT01533324 | S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 32 | Second Military Medical UniversityOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT01525719 | Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma(CRAD001T) | unknown | Phase 2 | 40 | Ratchavithi HospitalOTHER_GOV | 0 | Feb 3, 2012 | clinicaltrials |
| NCT01489566 | Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients | unknown | Phase 3 | 300 | Shenzhen Kangzhe Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 14, 2011 | clinicaltrials |
| NCT01441453 | Transient Elastography in Hepatectomy for Hepatocellular Carcinoma | unknown | N/A | 120 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Sep 27, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jul 4, 2014source: clinicaltrials